Vaccines and Preventable Diseases

• Pneumococcal Vaccination

  Brief Description

  Pneumococcal conjugate vaccine is recommended for all children less than 59 months old. In addition, children aged more than 24 months who are at high risk of pneumococcal disease and adults with risk factors may receive the pneumococcal polysaccaride vaccine.
  
  

  Vaccine Information

  The pneumococcal conjugate vaccine, PCV13 or Prevnar 13® is currently recommended for all children under 5 years of age.

  Pneumovax® is 23-valent polysaccharide vaccine (PPVSV) that is currently recommended for use in all adults who are older than 65 years of age and for persons who are 2 years and older and at high risk for disease (e.g., sickle cell disease, HIV infection, or other immunocompromising conditions). It is also recommended for use in adults 19 through 64 years of age who smoke cigarettes or who have asthma.